289
Participants
Start Date
June 19, 2012
Primary Completion Date
December 2, 2013
Study Completion Date
December 2, 2013
peficitinib
oral
Placebo
oral
Budai Irgalmasrendi Korhaz, Budapest
Orszgos Reumatolgiai s Fizioterpis Intzet, Budapest
Revita Clinic Rheumatology, Budapest
"MHAT Sv. Ivan Rilski", Sofia
MHAT Plovdiv AD, Plovdiv
Rethy Pal Korhaz es Rendelointezet, Békéscsaba
Cliditer S.A. de C.V., Mexico City
MHAT Burgas, Burgas
Altoona Center for Clinical Research, Duncansville
Clincal Research Center of Reading, Wyomissing
The Center for Rheumatology and Bone Research, Wheaton
Mountain State Clinical Research, Clarksburg
PMG Research, Hickory
Jacksonville Center for Clinical Research, Jacksonville
Arthritis Associates, Orlando
Achieve Clinical Research, LLC, Birmingham
Center for Arthritis and Osteoporosis, Elizabethtown
Dr Javier Orozco Alcala Private Doctor´s office, Guadalajara
Centro de Investigacion Clinica de Morelia, S.C., Morelia
Illinois Bone & Joint Institute; LLC, Morton Grove
Deerbrook Medical Asssociates, Vernon Hills
MEDICAL PLUS, s.r.o. or REVMACENTRUM UH, s.r.o., Uherské Hradiště
Health Research of Oklahoma, Oklahoma City
Austin Rheumatology Research PA, Austin
Arthritis Associates of Colorado Springs, Colorado Springs
Desert Medical Advances, Palm Desert
Pacific Arthritis Center Medical Group, Santa Maria
Stanford University School of Medicine, Palo Alto
University of California San Diego, La Jolla
Rheumatology Consultants, PLLC, Knoxville
Revmatologicky ustav, Prague
Revmatologicka ambulance, Praha-Nusle
PV-MEDICAL s.r.o., Zlín
Kenezy Hospital Institute of Clinical Pharmacology, Debrecen
Szpital Uniwersytecki nr. 2 im. Dr. Jana Biziela, Bydgoszcz
NZOZ Centrum Medyczne ProMiMed, Krakow
Zespol Poradni Specjalistycznych, REUMED sp. Zo.o, Lublin
ARS Rheumatica, Warsaw
Astellas Pharma Global Development, Inc.
INDUSTRY